Laidlaw & Co. Initiates Coverage On NewcelX with Buy Rating, Announces Price Target of $23

Benzinga Newsdesk www.benzinga.com Neutral 57.8%

Neg 0% Neu 57.8% Pos 0%

Laidlaw & Co. analyst Yale Jen initiates coverage on NewcelX (NASDAQ:NCEL) with a Buy rating and announces Price Target of $23.